The role of penicillin G potassium in managing Clostridium perfringens in broiler chickens.

The efficacy of penicillin G potassium (Pot-Pen) administered via drinking water to manage necrotic enteritis (NE) was investigated in a Clostridium perfringens (CP) challenge study using 1600 broiler chickens assigned to one of four treatment groups: nonchallenged, nonmedicated; challenged, nonmedicated; challenged, Pot-Pen 0.2 g/L; challenged, Pot-Pen 0.4 g/L. Overall mortality due to NE was significantly reduced among Pot-Pen-treated pens; mortality due to other causes did not differ among the treatment groups. Among all birds, growth performance parameters were significantly improved among Pot-Pen-treated pens. When considering birds randomly sacrificed 4 days post-Pot-Pen initiation, mean NE lesion scores were greatest among the challenged, nonmedicated pens; only one of 80 randomly sacrificed birds treated with Pot-Pen had NE lesions. Among the nonmedicated control pens, body weight (BW) was significantly greater among birds that did not have NE-associated lesions. When sacrificed birds were stratified by NE lesion score, there were no significant differences in BW among the treatment groups. Results of this study suggest that CP-associated subclinical disease can significantly reduce broiler performance. Furthermore, the positive effects of treatment with Pot-Pen appeared to be associated with the prevention and/or treatment of NE-specific lesions.

Feed and water consumption and performance of male and female broilers fed salinomycin and maduramicin followed by a withdrawal ration.

A 3 x 2 factorial floor pen experiment was conducted to determine the effects of feeding salinomycin (60 ppm) or maduramicin (5 ppm) for 49 days followed by a 3-day withdrawal ration upon both male and female broiler chickens in a coccidia-free environment. Body weights, feed intake, and water consumption were recorded at 28, 49, and 52 days of age. Feed efficiency and overall mortalities were also measured. Inclusion of either ionophore into the ration had no effect on final body weight, but improved feed conversion (P less than .05). Birds fed maduramicin drank more than the nonmedicated birds (P less than .05), which in turn, drank more than the birds fed salinomycin (P less than .05).

A new approach in the prevention of gastrointestinal parasitic infections in cattle.

The efficacy of a morantel long-acting device in preventing parasitic gastroenteric infections throughout a whole year was evaluated in heifers and steer calves in south central Québec. Thirty-two calves, comprising nine Hereford steers, one Hereford heifer, fourteen Holstein crossbred steers and eight Holstein crossbred heifers, were allotted into two treatment groups and maintained throughout the grazing season on adjacent pastures resulting from equivalently dividing one original pasture. One morantel long-acting device was administered to each animal in one group at the time of turnout onto the pasture in the spring while the calves in the other group remained as nonmedicated controls. The parasitic infections incurred during the pasture season were primarily Ostertagia, Trichostrongylus, Cooperia and Nematodirus.The following fall, after twelve calves were necropsied for worm counts, the twenty remaining ones were brought into the barn where they were kept throughout the winter with access to an outside yard. They received good quality hay and rolled barley (1 kg/head/day) up until the following May, at which time they were weighed and had fecal samples taken for egg counts. In contrast to the results observed among controls, the morantel long-acting device treatment group had an 87% reduction in fecal worm egg excretion and a 67.3 kg per calf increased weight gain after one year.

Efficacy of morantel tartrate on milk production of dairy cows: a field study.

Eighty Holstein herds on Quebec Dairy Herd Analysis Service were paired into 40 blocks of two herds each to test the effects of systematic deworming with morantel tartrate. Cows in treated herds were given morantel tartrate in May, June, and July, and cows in control herds were given a placebo of ground corn, wheat bran, and barley; both products were administered at 1 kg/1000 kg body weight. Records were obtained from May 1983 to April 1984. Each farm was visited monthly from May to October 1983 to obtain herbage samples and fecal grab samples from a random 10% of lactating cows. Production records were obtained for the year prior to commencement of this trial for covariate analysis. Fecal worm egg counts and infective larvae counts in pasture were reduced by 83 and 93%, respectively, in treated herds. The pattern of worm egg excretion differed between groups due to repeated treatments with morantel. Treated herds produced 323 kg more milk per cow per yr and 1.2 kg per cow per d more fat-corrected milk than controls. Milk fat and protein percentages did not differ between groups for the 12 mo. Deworming lactating dairy cows at the beginning of and during the pasture season improved production performance.

Oral loading of homogentisic acid in controls and in obligate heterozygotes for hereditary tyrosinemia type I.

Homogentisic acid (HGA) (50 mg/kg) was given orally to 22 obligate heterozygotes for hereditary tyrosinemia type 1 (HT) and to 11 controls. After 1 h the mean +/- standard error (SE) plasma level of HGA was 30.42 +/- 1.41 micrograms/ml in carriers and 19.29 +/- 1.62 in controls. Mean +/- SE fasting delta-amino-levulinate dehydratase (delta-ALD) was 40.05 +/- 1.79 m microM/min/g Hb in carriers, much lower than the 60.81 +/- 5.11 found in controls. After 3 h this difference in levels of delta-ALD remained, with mean +/- SE values of 25.70 +/- 2.89 m microM/min/g Hb in carriers, compared with 48.83 +/- 5.37 in controls. Three-hour mean +/- SE excretion of fumarylacetone "equivalent" [FAc] in urine in carriers, 51.597 +/- 5.580 micrograms/mg/creatinine, was significantly higher than the 27.941 +/- 5.916 in controls. Three-hour excretion of succinylacetone "equivalent" [SAc] was also significantly higher in the urine of carriers. FAc in 3-h urine was identified by thin-layer chromatography and confirmed by gas chromatography/mass spectrometry. Multivariate stepwise discriminant analysis showed that the inclusion order of significant variables was as follows: HGA levels at 1 hr, fasting level of delta-ALD, residual level of HGA at 3 h, and 3-h excretion of [FAc]. Non-significant variables were HGA tolerance, levels of delta-ALD at 3 h, sex, and 3-h excretion of [SAc].(ABSTRACT TRUNCATED AT 250 WORDS)

Production of a specific polyclonal antibody against the rat beta thyroid receptor, using synthetic peptide as antigen.

We have developed a polyclonal antibody to a synthetic peptide corresponding to the deduced amino acid residues 67-80 of the amino terminal sequence of the rat thyroid receptor beta cDNA. Immunopositive sera were identified by radioimmunoassay and purified by affinity chromatography. The antibody specifically immunoprecipitated the labelled thyroid receptor beta synthetized in vitro but not the rat thyroid receptor alpha. Furthermore, 38% of the L-T3 binding capacity of the rat liver nuclear receptor were immunoabsorbed by this antibody. By immunocytochemistry, this antibody stained specifically the nuclei of hepatocytes while no staining was observed in the rat testis. This study presents a specific polyclonal antibody against the thyroid receptor beta. This antibody will be of a great help in determining the role of the beta receptors in the mechanism of action of thyroid hormone.

Efficacy of morantel tartrate in a sustained release bolus on the control of subclinical gastrointestinal parasitism in first-year grazing dairy replacements.

Thirty-four heifers (24 Holstein, 8 Ayrshire, 2 Jersey) and 12 Holstein steer calves were grouped into 23 blocks of 2 animals each according to breed, sex, and body weight. Animals in each block were randomly assigned to control or treated groups. The treated group received an anthelmintic bolus containing morantel tartrate before they were permitted access to pasture. A 2.6 ha pasture was divided in half with a double fence; the resulting two pastures had separate feed and water troughs. Steer calves were slaughtered upon termination of the trial to ascertain gastrointestinal parasite burdens. Two worm-free tracer calves were placed on each pasture every 2 mo and slaughtered after 4 wk of grazing to determine parasite infectivity of pastures. Herbage samples were obtained monthly and analyzed for infective larvae. The trial was conducted for 141 d during the grazing season. Treatment resulted in 90% reduction in infective larvae on pasture, 74% reduction in fecal worm-eggs, 91% reduction in adult worm burdens, and a trend toward reduced worm burdens in tracer calves by 52%. An overall average daily gain of .68 and .88 kg was obtained for control and treated animals. Reproductive data for the heifers remaining in the herd from the trial showed that treatment resulted in 44 less days to first breeding.